基于的多阶段疫苗平台的设计和表征,以向Mycobacterium tuberculosis感染
Chiara Bellini1,2, Emil Vergara3, Fruzsina Bencs2,4
1MTA-TTK Lendület "Momentum" Peptide-Based Vaccines Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Budapest 1117, Hungary.
Bioconjugate chemistry
|August 22, 2023
概括
开发一种新的结核病疫苗是一项挑战. 一种新的棕化联体 (Pal-CGHP) 增强了细胞吸收和免疫反应,显示出有效结核疫苗接种的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 结核病 (TB) 疫苗开发面临挑战,原因是 Mycobacterium tuberculosis (Mtb) 复杂的免疫病理学,影响了对活性和潜伏阶段的疗效.
- 多阶段疫苗,结合两种病原体阶段的抗原,是一个有希望的策略,由当前的结核病疫苗临床管道支持.
研究的目的:
- 设计和描述一种新的多阶段基结核病疫苗平台.
- 为了评估与池 (PM1) 相比,棕化多基皮托结合物 (Pal-CGHP) 的免疫性和疗效.
主要方法:
- 选择的CD4+和CD8+T细胞表位 (CFP10,GlfT2,HBHA,PPE15) 用于一个多阶段的疫苗平台.
- 通过 thiol-maleimide 化学选择性结合合成了一种多种皮托普结合物 (Ac-CGHP).
- 在人类和小鼠抗原呈现细胞以及BALB/c小鼠中评估了Pal-CGHP的细胞吸收和免疫性.
主要成果:
- 池 (PM1) 在Mtb敏感的PBMC中触发了T细胞反应.
- 棕化结合物 (Pal-CGHP) 显示了细胞吸收的增强和免疫性改善.
- 与小鼠的PM1相比,Pal-CGHP诱导了显著更高的T细胞增殖和IFNγ和TNFα的产生.
结论:
- 设计的基于的疫苗平台显示,有可能诱导强大的T细胞对MTB的反应.
- 帕尔-CGHP代表了一种新的,有效的结核病疫苗的有前途的候选人,该疫苗针对活跃和潜伏阶段.
- 这项研究突出了结构-活性关系和棕化对增强疫苗疗效的益处.
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...


